Download pdf: MIMS Ireland Dec12 – Weight management in primary care. This includes: Weight Management Treatment Algorithm; Information for Weight Management in Primary Care; BMI Chart for Use with Weight Management Algorithm. Reference: [Adapted] Irish College of General Practitioners (ICGP). Weight management treatment algorithm, www.icgp.ie/weightmanagement, accessed 30 Oct 2012. See www.icgp.ie/weightmanagement for additional online resources. […]
Updated pharmacovigilance legislation
December 2, 2012 by Leave a Comment
Background Medicines save lives and relieve suffering but can also cause side effects. According to an Impact Assessment undertaken by the European Commission, 5% of all hospital admissions are for side effects, 5% of all hospital patients suffer a side effect to a medicine and side effects are the fifth most common cause of hospital […]
Calciup D3 Forte
December 1, 2012 by Leave a Comment
Company: Rowex Ltd. Legal category: Pharmacist only. GMS. Sport permitted. Active ingredients: Calcium (as carbonate) 1,000mg, colecalciferol 22mcg (equivalent to vitamin D3 880 IU). Description: White, round chewable tablet with break mark. Can be divided into equal halves. Presentation: 30, €4.74. Indications: Prevention and treatment of vitamin D (vit. D) and calcium (Ca++) deficiency in […]
Desunin
December 1, 2012 by Leave a Comment
Company: Meda Pharma. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Colecalciferol 20mcg (equivalent to vitamin D3 800IU). Description: White biconvex tablets. Presentation: 90, €9.80. Indication: Prevention and treatment of vitamin D (vit. D) deficiency. Pharmacology: Vit. D increases the intestinal absorption of calcium (Ca++) and phosphate. It counteracts development of osteomalacia in adults and […]
Fortisip Compact
December 1, 2012 by Leave a Comment
Company: Nutricia Advanced Medical Nutrition. Legal category: Nutrition. GMS. Nutritional Content: Protein 9.6g, fat 9.3g, carbohydrate 29.7g per 100ml plus vitamins, minerals and trace elements. Gluten free. 7 flavours (vanilla, strawberry, mocha, forest fruits, banana, chocolate & apricot). 300kcal/125ml. Plastic bottle with straw. Description: Nutritionally complete food. Presentation: 125ml, €1.38. Indications: Short bowel syndrome, intractable […]
Movicol Liquid
December 1, 2012 by Leave a Comment
Company: Norgine Pharmaceuticals Ltd. Legal category: Prescription. Sport permitted. Active ingredients: Macrogol 3350 (polyethylene glycol 3350) 13.125g, NaCl 350.7mg, NaHCO3 178.5mg, KCl 46.6mg (on reconstitution: Na+ 65mmol/l, Cl- 53mmol/l, K+ 5.4mmol/l, HCO3- 17mmol/l). Description: Orange flavoured liquid concentrate for oral solution. Presentation: 500ml, €7.71. Indication: Treatment of chronic constipation. Pharmacology: Macrogol 3350 increases stool volume, […]
Nutramigen AA
December 1, 2012 by Leave a Comment
Company: Mead Johnson Nutrition Legal category: Prescription. GMS. Nutritional Content: Protein (free amino acids)13.9g, carbohydrate 51g (glucose polymers, tapioca starch), fat (vegetable oils, LCPs )26g, vitamins, minerals, trace elements. Lactose-, sucrose- and gluten-free. 498kcal/100g. Description: Amino acid based nutritionally complete hypoallergenic infant formula. Presentation: 400g, €23.72. Indications: Management of infants with cow’s milk allergy, multiple […]
Rivastigmine Sandoz
December 1, 2012 by Leave a Comment
Company: Rowex Ltd. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Rivastigmine (as hydrogen tartrate) 1.5mg, 3mg, 4.5mg, 6mg. Description: Yellow, orange, red or red/orange hard capsules respectively, marked with RIV and capsule strength. Presentation: 1.5mg-56, €36.32; 3mg, 4.5mg and 6mg-56, €37.33. Indications: Symptomatic treatment of mild to moderately severe Alzheimer’s dementia or mild to […]
Trimega
December 1, 2012 by Leave a Comment
Company: Clonmel Healthcare Ltd. Legal category: Prescription. Sport permitted. Active ingredients: Omega-3-acid ethyl esters 90 1000mg (including EPA 460mg, DHA 380mg). Description: Soft yellow capsules. Presentation: 28, €17.76. Indications: Secondary prevention after myocardial infarction, in addition to other standard therapy. Endogenous hypertriglyceridaemia as a supplement to diet when dietary measures alone are insufficient to produce […]
Price reductions included in MIMS Ireland
December 1, 2012 by Leave a Comment
MIMS Ireland wish to announce that following the recent Agreement between IPHA and the DoH/HSE, a number of prices have been updated in the present issue (December 2012). The Agreement contained a number of measures in relation to price reduction including: • the price of medicines marketed by IPHA companies which are off-patent prior to […]
Loading ...
